Catalyst Wire Dossier Catalyst Wire Dossier

Mericitabine

mericitabine · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Mericitabine, covering 2016-08-05 to 2017-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C [Phase 2]

See pricing